Edith Cowan University

Research Online
Research outputs 2022 to 2026
1-1-2022

5-HT2 receptor antagonism reduces human motoneuron output to
antidromic activation but not to stimulation of corticospinal axons
Jacob R. Thorstensen
Janet L. Taylor
Edith Cowan University, janet.taylor@ecu.edu.au

Justin J. Kavanagh

Follow this and additional works at: https://ro.ecu.edu.au/ecuworks2022-2026
Part of the Neurosciences Commons
10.1111/ejn.15672
Thorstensen, J. R., Taylor, J. L., & Kavanagh, J. J. (2022). 5‐HT2 receptor antagonism reduces human motoneuron
output to antidromic activation but not to stimulation of corticospinal axons. European Journal of Neuroscience,
56(1), 3674-3686. https://doi.org/10.1111/ejn.15672
This Journal Article is posted at Research Online.
https://ro.ecu.edu.au/ecuworks2022-2026/908

Received: 18 January 2022

Revised: 19 March 2022

Accepted: 7 April 2022

DOI: 10.1111/ejn.15672

RESEARCH REPORT

5-HT2 receptor antagonism reduces human motoneuron
output to antidromic activation but not to stimulation of
corticospinal axons
Jacob R. Thorstensen1

|

Janet L. Taylor2,3

|

Justin J. Kavanagh1

1

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia

2

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia

3

Neuroscience Research Australia, Sydney, New South Wales, Australia

Correspondence
Jacob R. Thorstensen, Child Health
Research Centre, Faculty of Medicine,
The University of Queensland, Centre for
Children’s Health Research, South
Brisbane QLD 4101, Australia.
Email: j.thorstensen@uq.edu.au
Edited by: Francisco Alvarez

Abstract
The intrinsic electrical properties of motoneurons strongly affect motoneuron
excitability to fast-acting excitatory ionotropic inputs. Serotonin (5-HT) is a
neurochemical that alters the intrinsic properties of motoneurons, whereby
animal models and in vitro experiments indicate that 5-HT increases motoneuron excitability by activating 5-HT2 receptors on the somato-dendritic compartment. In the current study, we examined how antagonism of the 5-HT2
receptor affects motoneuron excitability in humans. We hypothesised that motoneuron excitability would be reduced. The 5-HT2 antagonist cyproheptadine
was administered to 10 healthy participants in a double-blinded, placebocontrolled, crossover trial. Electrical cervicomedullary stimulation was used to
deliver a synchronised excitatory volley to motoneurons to elicit cervicomedullary motor evoked potentials (CMEPs) in the surface electromyography (EMG) signal of the resting biceps brachii. Likewise, electrical peripheral
nerve stimulation was used to generate antidromic spikes in motoneurons and
cause recurrent discharges, which were recorded with surface EMG as F-waves
in a resting hand muscle. Compared with placebo, we found that 5-HT2 antagonism reduced the amplitude and persistence of F-waves but did not affect CMEP
amplitude. 5-HT2 antagonism also reduced maximal contraction strength. The
reduced recurrent discharge of motoneurons with 5-HT2 antagonism suggests
that 5-HT2 receptors modulate the electrical properties of the initial segment or
soma to promote excitability. Conversely, as cyproheptadine did not affect motoneuron excitability to brief synaptic input, but affected maximal contractions
requiring sustained input, it seems likely that the 5-HT2-mediated amplification

Abbreviations: 5-HT, serotonin; ADM, abductor digiti minimi; CMEP, cervicomedullary motor evoked potential; CNS, central nervous system;
EMG, electromyography; EPSP, excitatory post-synaptic potential; Mmax, maximal compound muscle action potential; MVC, maximal voluntary
contraction; PICs, persistent inward currents; SSRI, selective serotonin reuptake inhibitor.
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of synaptic input at motoneuron dendrites is functionally significant only when
excitatory input activates persistent inward currents.
KEYWORDS
cervicomedullary motor evoked potential, F-wave, ionotropic, neuromodulation, raphe
nuclei, serotonin

1 | INTRODUCTION
The intrinsic electrical properties of motoneurons markedly influence the magnitude of excitatory post-synaptic
potentials (EPSPs) arising from fast-acting excitatory
ionotropic inputs (Heckman & Enoka, 2012). Motoneuronal properties are heavily affected by the release of
neuromodulators arising from descending brainstem projections (Heckman et al., 2009; Heckman & Enoka, 2012;
Rekling et al., 2000). Serotonin (5-HT) is an example of a
neuromodulator that has strong effects on motoneuron
excitability (i.e., the output of motoneurons to excitatory
input). The release of central nervous system (CNS) 5-HT
is predominantly controlled by the brainstem raphe
nuclei (Hornung, 2003), but there are also intraspinal
5-HT producing neurons (Zhang, 2015). Descending
raphe projections form direct monosynaptic connections
with the dendrites and soma of motoneurons (Alvarez
et al., 1998; Pilowsky et al., 1990; Ridet et al., 1994). At
motoneurons, 5-HT enhances the efficacy of ionotropic
inputs through the activation of metabotropic receptors
coupled to G-proteins (Heckman et al., 2009; Perrier
et al., 2013). Specifically, metabotropic 5-HT receptors
modulate the electrical properties of motoneurons to promote recruitment and discharge, so that motoneurons
are brought above their threshold for discharge, and discharge more frequently, with smaller magnitudes of
ionotropic input (Perrier et al., 2013).
Experiments performed in adult turtle spinal cord slice
preparations demonstrate that 5-HT increases motoneuron
excitability by activating 5-HT2 receptors on the somatodendritic compartment (Hsiao et al., 1997; Perrier &
Hounsgaard, 2003). The facilitatory effects of 5-HT2 receptor activation on dendritic persistent inward currents
(PICs) are especially strong (Harvey et al., 2006a, 2006b;
Murray, Stephens, Ballou, et al., 2011; Perrier & DelgadoLezama, 2005; Perrier & Hounsgaard, 2003). PICs amplify
ionotropic input significantly and promote the sustained
discharge of motoneurons, and the amplitude of PICs
appear to correspond closely to the amount of 5-HT available to activate 5-HT2 receptors on motoneurons
(Heckman et al., 2003, 2009; Heckman, Hyngstrom, &
Johnson, 2008). It is important to highlight that a
sustained depolarizing current is usually needed to

activate PICs (Heckman, Johnson, et al., 2008). In voluntary contractions, this comprises sustained ionotropic
input from the corticospinal system, and other descending
and sensory afferent pathways, that slowly brings motoneurons above their threshold for discharge. In this
regard, 5-HT puts PICs in a facilitated state but does not
cause motoneuronal activation, and 5-HT-mediated
increases in motoneuron excitability are strongest when
PICs are activated by excitatory input (Heckman
et al., 2009).
In addition to facilitatory effects on PICs, which are
activated by sustained excitatory input and enhance
motoneuron output, 5-HT2 receptors also modulate the
resting membrane potential of motoneurons to increase
excitability (Perrier et al., 2013; Perrier & Cotel, 2015).
Specifically, 5-HT2 receptors inhibit leak potassium channels and facilitate a hyperpolarization activated inward
current (Hsiao et al., 1997). Together, these actions depolarize the resting membrane potential of motoneurons to
lower the magnitude of ionotropic input needed for
recruitment. If 5-HT increases the excitability of motoneurons in slice preparations and animal models, 5-HT
could also increase the in vivo excitability of motoneurons in human participants. In support of this proposition, studies using drug interventions indicate that 5-HT2
receptors are particularly important and indeed act to
increase human motoneuron excitability. For example,
5-HT2 antagonists reduce spasticity after spinal cord
injury by blocking constitutive 5-HT2 receptor activity at
motoneurons (D’Amico, Murray, et al., 2013; Murray
et al., 2010). Likewise, in neurologically healthy individuals, 5-HT2 antagonism reduces the amplitude of muscle
responses to motor cortical stimulation (Thorstensen
et al., 2021), decreases estimates of PIC amplitude
(D’Amico, Murray, et al., 2013) and reduces force variability (Wei et al., 2014). However, motor cortical stimulation and voluntary contractions first activate sites
upstream of motoneurons (that are also affected by 5-HT
active drugs), so it is not known if/how 5-HT2 antagonism affects human motoneuron excitability directly.
The purpose of this study was to examine if antagonism of the 5-HT2 receptor affects human motoneuron
excitability. Under conditions of 5-HT2 antagonism, submaximal stimulation of corticospinal axons at the level of
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obtained before (baseline) and after (post-pill) placebo
and drug administration during the two testing days.

the cervicomedullary junction was used to deliver a
synchronised excitatory volley to motoneurons and evoke
cervicomedullary motor evoked potentials (CMEPs) in
the resting biceps brachii. Cervicomedullary stimulation
rapidly brings motoneurons above their threshold for discharge and causes motoneurons to discharge only once
(Berardelli et al., 1991), such that CMEPs are unlikely to
reflect the 5-HT2 receptor modulation of PICs. We also
used supramaximal stimulation of motoneuron axons to
generate antidromic spikes and cause the recurrent discharge of motoneurons, which were recorded as Fwaves in a resting hand muscle. F-waves do not reflect
the synaptic activation of motoneurons and are probably
sensitive to the excitability of the axon initial segment
and soma (McNeil et al., 2013). Compared with placebo,
we hypothesised that both the synaptic and antidromic
activation of motoneurons would generate muscle
responses that were smaller in amplitude and less persistent for F-waves, after administration of a 5-HT2
antagonist.
As serotonergic projections to the spinal cord are diffuse (Bowker et al., 1982; Heckman, Hyngstrom, &
Johnson, 2008; Holstege & Kuypers, 1987) and voluntary
motor activity causes 5-HT release to the spinal cord
(Jacobs et al., 2002; Veasey et al., 1995; Wei et al., 2014),
we also examined CMEPs after a strong contraction of
the contralateral limb and hypothesised that 5-HT2 receptor antagonism would lead to greater reductions in motoneuron excitability at this time because of the stronger
influence of 5-HT. Maximal contraction performance was
also assessed to determine if 5-HT2 receptor antagonism
affected voluntary motor output. Overall, we found that
F-waves but not CMEPs were reduced by 5-HT2 antagonism, thus indicating that 5-HT2 antagonism reduces
motoneuronal recurrent discharge but not excitability to
brief synaptic input. We also found that 5-HT2 antagonism reduced maximal contraction strength, which suggests that the 5-HT-mediated amplification of synaptic
input at motoneurons is strong only when motoneurons
fire repetitively and dendritic PICs are activated.

Twelve healthy participants were initially recruited for
this study. Participants were screened using a medical
history questionnaire which contained exclusion criteria
specific to nervous system and upper-limb musculoskeletal injury, cyproheptadine administration and electrical
stimulation. Recruited participants also attended a
familiarisation session, where we ensured that participants could tolerate cervicomedullary stimulation and
that biceps brachii responses to cervicomedullary stimulation were free of early latency components. An early
onset latency of an evoked potential from cervicomedullary stimulation signifies the direct stimulation
of cervical nerve roots (see Section 2.6). During
familiarisation, three participants displayed early latency
components to cervicomedullary stimulation and were
excluded from testing because of this. The remaining
nine participants completed both the cervicomedullary
stimulation and F-wave components of the study, and
one excluded participant opted to complete the F-wave
component only (n = 10 were administered drug, participant age: 26.3  4.1 years old, three female). Participants
were asked to refrain from any stimulants or depressants
such as caffeine, alcohol or exercise on the morning of
testing until testing had finished for the day.

2 | MATERIALS AND METHODS

2.4 | Drug intervention

2.1 | Experimental design

A single 8-mg oral dose of the 5-HT2 receptor antagonist
cyproheptadine, or a placebo, was administered to participants immediately after baseline measurements were
obtained. Post-pill testing commenced after 3 h had passed from pill administration. The drug and placebo capsules were similar in appearance, where the placebo
contained non-active excipients frequently used in drug
compounding. Although also an antihistamine, cyproheptadine has strong antiserotonin effects. In human

This study was a human, double-blind, placebocontrolled, counterbalanced crossover study. Participants
attended the laboratory on two occasions separated by a
minimum of 1 week. At one testing session, cyproheptadine was administered to examine how 5-HT2 antagonism affects the excitability of motoneurons projecting to
resting muscle. Measures of motoneuron excitability were

2.2 | Ethical approval
Ethical approval was obtained via the Human Research
Ethics committee at Griffith University (Griffith University Reference Number: 2019/339), and written informed
consent was obtained prior to testing. All testing procedures were performed in accordance with the Declaration
of Helsinki.

2.3 | Participants
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neurophysiology experiments, a standardised 8-mg dose
of cyproheptadine has been used to attenuate the postsynaptic effects of the 5-HT2 receptor at motoneurons
(D’Amico, Murray, et al., 2013; Murray et al., 2010; Seo
et al., 2011; Thorstensen et al., 2021; Wei et al., 2014).

2.5 | Participant setup and EMG
Participants sat upright in a chair with both arms by
their side. Both elbows were positioned in 90 of flexion, and the right wrist was supinated with the palm
upwards. The right arm for each participant was firmly
strapped to an armrest at the elbow, wrist and fingers to
prevent changes in upper-limb position during testing.
Surface electromyography (EMG) signals were obtained
from the right biceps brachii and abductor digiti
minimi (ADM) via Ag/AgCl electrodes (Kendall ARBO,
24 mm diameter). A belly-tendon arrangement was
employed for both the biceps brachii and ADM. All
biceps brachii and ADM EMG were amplified (100 or
300) and bandpass filtered between 10 and 1000 Hz
(CED 1902, Cambridge Electronic Design Ltd., UK),
and sampled at 5000 Hz using a Power 1401 data acquisition interface with Signal software (version
6, Cambridge Electronic Design Ltd., UK). For the
ADM, an additional channel was used to collect EMG
for F-wave analysis. This channel was highly amplified
(1000) and highly filtered (bandpass between 200 and
1000 Hz) to reduce the duration of the M-wave tail such
that it was easier to identify F-waves (D’Amico
et al., 2017; Khan et al., 2012, 2016).

3677

a level that elicited a resting biceps brachii CMEP amplitude of 10% of the biceps maximal compound muscle
action potential (Mmax, range: 105–215 mA). To assess
the effect of drug administration on CMEPs, this stimulation intensity was fixed for the remainder of each testing session. The onset latency of CMEPs was monitored
throughout testing to ensure activation of biceps brachii
motoneurons via synaptic input. The onset latency for
biceps CMEPs is typically ≥8 ms (Taylor &
Martin, 2009; Ugawa et al., 1991). Likewise, a sudden
2-ms decrease in latency suggested that cervicomedullary stimulation activated the axons of cervical motoneurons (Petersen et al., 2002; Taylor, 2006;
Taylor & Gandevia, 2004).

2.7 | Brachial plexus stimulation
Electrical stimuli were applied to axons of biceps brachii
motoneurons at the brachial plexus to generate a biceps
Mmax. A constant current stimulator (DS7AH, Digitimer
Ltd., UK) with a pulse width of .2 ms was used to deliver
stimulation. A surface cathode was positioned overlying
the supraclavicular fossa at Erb’s point, and a surface
anode was positioned on the acromion. For the placebo
and cyproheptadine sessions, stimulator intensity was
set at 130% of the current used to obtain a maximal
evoked biceps brachii EMG response before pill ingestion (range: 52–156 mA). Once this stimulator intensity
was determined, it remained fixed throughout the testing session.

2.8 | Ulnar nerve stimulation
2.6 | Cervicomedullary stimulation
Electrical stimuli were applied to corticospinal axons at
the level of the cervicomedullary junction to elicit
CMEPs in the resting biceps brachii. This muscle was
chosen as the threshold for eliciting resting biceps
CMEPs is typically lower compared with distal muscles
of the upper limb, thus minimising participant discomfort associated with higher intensity cervicomedullary
stimulation. A constant current stimulator (DS7AH,
Digitimer Ltd., UK) was used to deliver stimuli with a
pulse width set at .2 ms. A surface cathode was placed
overlying the left mastoid process, and a surface anode
was placed overlying the right mastoid process. This
configuration generated a current that was less likely to
activate axons of cervical motoneurons projecting to the
right biceps, as depolarization of peripheral nerves are
more probable near the cathode. For the placebo and
cyproheptadine sessions, stimulator intensity was set to

Because the appearance of F-waves in the biceps brachii
EMG signal can be masked by the tail of the preceding
M-wave, we selected a distal upper-limb muscle to
record F-waves with a longer onset latency. Hence, electrical stimuli were applied to the ulnar nerve at the
wrist to generate F-waves in the ADM. A constant current stimulator (DS7AH, Digitimer Ltd., UK) with a
pulse width of .2 ms was used to generate the antidromic wave in the ulnar nerve. A surface cathode and
anode were positioned 2 cm apart, where the anode
was positioned distal to the cathode and 2–3 cm proximal to the wrist joint. All ulnar nerve stimuli were supramaximal (150% of the current used to obtain a resting
ADM Mmax, range: 45–105 mA). This supramaximal
intensity was determined prior to pill ingestion and
remained fixed within each testing session. There was a
2-s interval (.5-Hz stimulation frequency) between each
ulnar nerve stimulation.
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2.9 | Experiment protocol
After the participant was prepared for testing, and relevant stimulation intensities were determined, three
blocks of baseline stimulations were completed
(Figure 1). Within each block, five cervicomedullary
stimuli were used to obtain CMEPs and three brachial
plexus stimuli were used to obtain Mmax for the biceps
brachii. There were 10-s inter-stimulus intervals between
all cervicomedullary and brachial plexus stimuli. Each
block also contained 60 ulnar nerve stimuli. Following
baseline measurements, participants ingested a placebo
or cyproheptadine. Three hours after pill administration,
a further five stimulation blocks were obtained to assess
post-pill changes in evoked responses. All stimulation
blocks were separated by 5 min. Before baseline and
post-pill testing, we ensured participants were in a comfortable position before measurements were obtained,
and we asked participants to rest with no movement for
5 min to ensure they were relaxed before stimulations
were delivered. Throughout testing, participants were
instructed to minimise voluntary movement, and EMG
was monitored during stimulation blocks to ensure muscles were free of voluntary activity.
Additional data were collected to determine if remote
contraction of the contralateral limb affected CMEPs
under conditions of 5-HT2 antagonism. Voluntary contraction of a remote muscle group, such as the opposite
non-test limb, likely promotes diffuse serotonergic drive
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to the spinal cord, which will affect nearby motoneuron
pools innervating contralateral homologous muscles
(e.g., the biceps of the test limb) (Wei et al., 2014). All
muscle contractions in this experiment were performed
at the end of testing on both days so that voluntary activity did not affect baseline and post-pill measures of resting motoneuron excitability. For all contractions, the
wrist of the left limb was attached to a calibrated load cell
(1100-N capacity, SM-250 S-type, Interface Inc., USA)
via a non-compliant strap. Participants initially performed three brief (2 to 3 s) maximal voluntary contractions (MVCs) to obtain an estimate of maximal force
generating capability for the non-test limb. For MVCs,
real-time visual feedback of force and verbal encouragement were provided to ensure each participant was contracting at maximal effort. After peak MVC force was
established, participants generated five brief (4 s) isometric elbow flexions at 75% MVC, where each contraction was followed by cervicomedullary and brachial
plexus stimulations approximately 1 and 3 s after contraction. EMG responses to cervicomedullary and brachial
plexus stimulation were measured in the relaxed right
biceps brachii directly after each contraction. Participants
were instructed to immediately relax both limbs after contraction of the left limb so that all stimulations were
applied when the right biceps brachii was at rest. Biceps
EMG was monitored to ensure the elbow flexors of the test
limb were relaxed. All contractions were separated by
2 min to minimise fatigue and standardise rest periods.

F I G U R E 1 Experiment protocol used to assess motoneuron excitability. Participants attended two sessions where a placebo or
cyproheptadine was administered. Baseline and post-pill measures were made for cervicomedullary motor evoked potentials (CMEPs, closed
arrows) and F-waves (clustered vertical lines). Brachial plexus stimuli were also used to obtain biceps maximal compound muscle action
potentials (Mmax, open arrows). Three blocks of baseline stimulations and five blocks of post-pill stimulations were delivered. Each block
included 5 biceps CMEPs, 3 biceps Mmax, and 60 stimuli for F-waves. Blocks were separated by 5 min. After resting measurement blocks
were completed, brief submaximal elbow flexions (at 75% of maximal voluntary contraction, MVC) were performed with the contralateral
limb. Directly after each contraction of the contralateral limb, responses to cervicomedullary and brachial plexus stimulation were recorded
(single submaximal contraction and stimulations = 1 block). Five submaximal contraction blocks were completed for post-ingestion
conditions separated by 2 min

THORSTENSEN ET AL.

2.10 | Data analysis
The peak-to-peak amplitudes of CMEPs and Mmax were
calculated from the biceps EMG signal. Average CMEP
amplitudes were first normalised to average Mmax amplitudes, and post-pill CMEP amplitudes were normalised
to baseline amplitudes to account for between-session differences. The peak-to-peak amplitudes of F-waves were
extracted from heavily filtered EMG data and normalised
to heavily filtered Mmax amplitudes. Average post-pill Fwave amplitudes were then normalised to baseline amplitudes. In addition to amplitude measures, F-wave persistence was calculated by counting the number of times an
F-wave was present relative to the number of ulnar nerve
stimuli. We deemed an F-wave to be present if there was
a clear waveform response with an amplitude ≥ 20 μV
within the 25- to 50-ms time window after stimulation.
Baseline F-wave persistence values were subtracted from
post-pill persistence values so that a negative value
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represents a reduction from baseline. All CMEP and Fwave data are presented in figures as either a percentage
(%) of baseline or change from baseline. Change scores
were also calculated for post-pill measures as a difference
from placebo values (cyproheptadine–placebo), and these
change scores are also presented in figures. A negative
change score denotes a reduction in amplitude or persistence for the cyproheptadine condition relative to placebo. All data were analysed using Signal software
(version 6, Cambridge Electronic Design Ltd., UK).

2.11 | Statistical analysis
Shapiro–Wilk tests were used to assess normality. To
identify differences between drug conditions, two-tailed
paired samples t tests were employed for peak MVC
force, CMEP amplitude and F-wave amplitude. Data
were not normally distributed for F-wave persistence,

F I G U R E 2 Changes in biceps brachii cervicomedullary motor evoked potential (CMEP) amplitude after placebo (PLA) and
cyproheptadine (CYP) administration. (a) Waveform averages of biceps CMEPs are shown for a single participant before (baseline) and after
(post-pill) administration of placebo (top panel) and cyproheptadine (bottom panel). Baseline traces are the average of 15 CMEPs and postpill traces are the average of 25 CMEPs. Dotted horizontal traces denote the maximum and minimum waveform responses at baseline for
each drug condition. (b) Post-pill CMEP amplitudes are shown for the group (mean  SD, n = 9). Individual values for each participant are
also shown. CMEP amplitudes were first normalised to the amplitude of the maximal compound muscle action potential (Mmax), and then
normalised to baseline CMEP (% of Mmax) values. (c) Individual post-pill CMEP amplitudes are shown for the cyproheptadine condition,
where cyproheptadine amplitudes are presented as a difference from post-pill placebo values to show the direction of change for each
participant after drug intake (cyproheptadine minus placebo)
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TABLE 1
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Biceps brachii and abductor digiti minimi (ADM) maximal compound muscle action potential (Mmax) amplitude values
Resting muscle

Post-contralateral contraction

Pre-PLA

Pre-CYP

Post-PLA

Post-CYP

Post-PLA

Biceps brachii (mV)

18.3  6.8

18.0  8.4

19.4  7.4

19.6  9.3

19.2  7.7

ADM (mV)

17.3  2.4

18.0  2.1

17.9  2.2

17.8  2.3

—

Post-CYP
19.7  9.2
—

Note: ADM is abductor digiti minimi, PLA is placebo, and CYP is cyproheptadine. ADM M-waves were obtained from wide band pass EMG signals. Data are
presented as group means  SD (n = 9 for biceps brachii and n = 10 for ADM).

F I G U R E 3 Changes in abductor digiti minimi F-wave amplitude and persistence after placebo (PLA) and cyproheptadine (CYP)
administration. (a) Individual F-waves are shown for a single participant before (baseline) and after (post-pill) administration of placebo (top
panel) and cyproheptadine (bottom panel). Thirty consecutive responses to stimulation are overlaid for each collection of traces. F-waves are
shown without the preceding M-wave, and each trace is the time window from 24 to 50 ms after stimulation. (b) Post-pill F-wave amplitudes
are shown for the group. Individual values for each participant are also shown. Individual F-wave amplitudes were first normalised to the
amplitude of the maximal compound muscle action potential (Mmax), and then normalised to baseline F-wave (% of Mmax) values.
(c) Individual post-pill F-wave amplitudes are shown for the cyproheptadine condition, where cyproheptadine amplitudes are presented as a
difference from post-pill placebo values to show the direction of change for each participant after drug intake (cyproheptadine minus
placebo). (d) Change in post-pill F-wave persistence values are shown for the group. Individual values for each participant are also shown.
For one participant, their cyproheptadine value ( 50.1%) is outside the y-axis limits. (e) Individual post-pill F-wave persistence values are
shown for the cyproheptadine condition, where cyproheptadine persistence values are presented as a difference from post-pill placebo
values. For panels (b) and (d), values are mean  SD (n = 10), and ‘*’ denotes a significant difference between drug conditions (P < .05)

THORSTENSEN ET AL.

and a Wilcoxon signed-rank test was used. All statistical
tests were completed using SPSS Statistics (version
27, IBM Corp., USA). A P value of <.05 was considered
statistically significant. All group data are presented in
the text and figures as mean  SD.
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and cyproheptadine conditions (t8 = .22, P = .83,
Figure 2b). Figure 2c shows individual change from placebo values for post-pill cyproheptadine CMEP
amplitude data.

3.2 | F-waves
3 | R E SUL T S
3.1 | Cervicomedullary motor evoked
potentials
Waveform averages of raw biceps CMEPs are shown for a
single participant in Figure 2a. Before pill administration,
the amplitude of baseline CMEPs for the group was
9.7  5.7% of Mmax for the placebo session and
8.1  3.4% of Mmax for the cyproheptadine session. Biceps
Mmax amplitudes are presented in Table 1. Post-pill
CMEP amplitude was not different between the placebo

Raw ADM F-waves are shown for a single participant in
Figure 3a. Before pill administration, baseline F-wave
amplitude for the group was 2.6  .6% of Mmax for the
placebo session and 2.5  .8% of Mmax for the cyproheptadine session. ADM Mmax amplitudes are presented in
Table 1. Baseline F-wave persistence was high. For the
group, persistence was 95.9  2.8% for the placebo session and 91.6  9.4% for the cyproheptadine session.
Cyproheptadine administration had a strong effect on
both F-wave amplitude and persistence, whereby drug
administration reduced both measures (cyproheptadine

F I G U R E 4 Biceps brachii cervicomedullary motor evoked potential (CMEP) amplitude after a brief contraction of the contralateral
elbow flexors with placebo (PLA) and cyproheptadine (CYP) administration. (a) Raw traces of elbow flexion force generated from the left
limb (upper trace) and biceps EMG recorded from the right limb (lower trace). Participants generated brief elbow flexions of the left limb at
75% of maximal voluntary contraction (MVC), before receiving cervicomedullary and brachial plexus stimulations at rest to evoke muscle
responses in the right biceps. (b) Post-contraction CMEP amplitudes are shown for the group (mean  SD, n = 9). Individual values for each
participant are also shown. CMEP amplitudes were first normalised to the amplitude of the maximal compound muscle action potential
(Mmax, also post-contraction), and then normalised to baseline pre-pill CMEP (% of Mmax) values. (c) Individual post-contraction CMEP
amplitudes are shown for the cyproheptadine condition, where cyproheptadine amplitudes are presented as a difference from postcontraction placebo values to show the direction of change for each participant after drug intake (cyproheptadine minus placebo)
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amplitude:
30.1  22.3% difference from placebo,
cyproheptadine persistence:
8.4  12.2% difference
from placebo). The amplitude of post-pill F-waves was
significantly different between the placebo and cyproheptadine conditions (t9 = 4.26, P = .002, Figure 3b). Similarly, post-pill F-wave persistence was different between
drug conditions (Z = 2.50, P = .013, Figure 3d).
Figure 3c,e shows individual change from placebo values
for post-pill cyproheptadine amplitude and persistence
data, respectively.

remote muscle activity. Yet 5-HT2 antagonism reduced
maximal contraction strength (i.e., when synaptic input
generates repetitive firing of motoneurons to activate
PICs). Overall, these results provide novel, in vivo,
human evidence that 5-HT2 receptors control the excitability of motoneurons, as evidenced by changes in recurrent discharge after drug administration. In addition, our
results indicate that 5-HT2 receptors modulate responses
to synaptic input, but only when synaptic input activates
5-HT2 receptor mediated dendritic PICs.

3.3 | The effects of contralateral
contraction on CMEPs

4.1 | 5-HT2 antagonism does not affect
CMEPs

After resting measures had been obtained, participants
performed brief MVCs of the left contralateral elbow
flexors to determine relevant target contraction intensities for the additional experiment and to establish if the
cyproheptadine intervention affected maximal motor output. Indeed, we identified a difference between drug conditions for MVC force (t9 = 2.97, P = .016), where MVC
force for the cyproheptadine condition (284.6  74.5 N)
was less than placebo (303.6  88.5 N). Although maximal motor output was affected by drug administration,
cyproheptadine did not affect CMEP amplitude measured
in the right limb when cervicomedullary stimuli were
delivered immediately after submaximal contraction of
the left limb (Figure 4). After submaximal elbow flexion
of the left contralateral limb, there was no difference
between the placebo and cyproheptadine conditions for
biceps CMEP amplitude (t8 = .084, P = .93).

We used cervicomedullary stimulation to deliver a brief
excitatory volley to motoneurons and recorded the size of
the resultant EMG response. Stimulation at the cervicomedullary junction provided a way to assess motoneuron output in response to synaptic input from
descending motor pathways (McNeil et al., 2013;
Taylor, 2006; Taylor & Gandevia, 2004), where CMEPs
have a strong monosynaptic component for the biceps
brachii (Petersen et al., 2002). As stimulation intensity
was fixed from baseline, cervicomedullary stimulation
activated the same number/type of corticospinal axons
and caused similar excitation of motoneurons throughout
each session. However, even though the synaptic excitation of motoneurons was controlled, 5-HT2 antagonism
had no effect on the output of motoneurons to input provided by a single synchronous volley from descending
motor pathways.
Although 5-HT2 receptors modulate the resting membrane properties of motoneurons to enhance motoneuron
excitability (Hsiao et al., 1997), 5-HT2 receptors exert
their most powerful effects on motoneuron excitability by
facilitating voltage-gated PICs (Harvey et al., 2006a,
2006b; Murray, Stephens, Ballou, et al., 2011; Perrier &
Delgado-Lezama, 2005; Perrier & Hounsgaard, 2003).
However, activation of PICs in motoneurons, and especially activation of calcium PICs (Elbasiouny et al., 2006),
requires a sustained synaptic excitation. Thus, 5-HT2
receptor effects on PICs will not be reflected in the amplitude of muscle responses to single-pulse cervicomedullary stimulation. With stimulation of
corticospinal axons, motoneurons receive a brief,
synchronised input and quickly go from below to above
their threshold for discharge. This leaves little time for
PICs to activate and influence the intrinsic properties of
motoneurons and hence, the amplitude of the CMEP. In
decerebrate cat preparations, self-sustained motoneuron
firing can be elicited with a high-frequency 1.5-s activation of Ia afferents that brings motoneurons above their

4 | DISCUSSION
This study examined if 5-HT2 receptor antagonism affects
human motoneuron excitability. Specifically, we assessed
the effects of 5-HT2 antagonism on the synaptic activation of motoneurons via cervicomedullary stimulation,
and the antidromic activation and recurrent discharge of
motoneurons via peripheral nerve stimulation. Cervicomedullary stimulation delivers a synchronised excitatory volley to motoneurons to evoke a compound
muscle action potential but does not cause motoneurons
to discharge repetitively and is unlikely to activate PICs.
We found that muscle responses from cervicomedullary
stimulation were not affected by 5-HT2 antagonism, but
5-HT2 antagonism reduced recurrent motoneuron discharge. We also assessed the synaptic activation of motoneurons after a strong contraction of the contralateral
limb and found that 5-HT2 antagonism did not affect
muscle responses to cervicomedullary stimulation after
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threshold for discharge but provides sufficient time for
PICs to activate (Lee & Heckman, 1998). Likewise, in
humans, a high-frequency vibration applied for 8 s to the
wrist generates a reflexive response that is enhanced by a
selective 5-HT reuptake inhibitor (SSRI), an effect that is
likely due to a 5-HT facilitation of PICs (Wei et al., 2014).
These methods contrast with cervicomedullary stimulation which generates a single EPSP in motoneurons and
does not cause repetitive discharge.
The proposition that a sustained depolarizing input is
needed to activate PICs, and a reduced PIC facilitation
with 5-HT2 antagonism will not reduce motoneuron
excitability to a brief synaptic volley, also explains why
we identified no drug differences for CMEPs after strong
contralateral contraction. In the current study, voluntary
contractions of the opposite limb were intended to
enhance 5-HT concentration in the spinal cord (Jacobs
et al., 2002; Veasey et al., 1995), but PICs in motoneurons
projecting to the biceps of the test limb were not active as
this muscle was relaxed. We postulate that serotonergic
effects after contralateral contraction may be revealed
with activation of PICs, for example, if participants voluntarily activate motoneurons projecting to the test
biceps. The serotonergic modulation of PICs after remote
muscle activity has been indirectly demonstrated in
humans. In healthy participants, the variability of muscle
contraction force is increased with enhanced 5-HT availability and reduced with 5-HT2 antagonism, and the magnitude of these increases or decreases in force variability
is in proportion to the strength of a preceding voluntary
contraction from the contralateral limb (Wei et al., 2014).
In this example, changes in force variability were likely
mediated by the modulation of PICs by the 5-HT drugs,
but PICs were only activated by voluntary contraction. It
seems unlikely that the lack of drug effects on postcontraction CMEPs in our study were due to the temporal characteristics of 5-HT reuptake in synapses, as
increased motoneuron excitability from 5-HT release has
been detected up until 8.5 s after stimulation of the raphe
nuclei in turtle preparations (Perrier & DelgadoLezama, 2005). In our protocol, CMEPs were obtained
1 s after contraction, which means that the effects of
5-HT release were still present when measurements of
motoneuron excitability were made.

4.2 | F-waves are reduced with 5-HT2
antagonism
Another way to assess motoneuron excitability is to measure the amplitude and persistence of recurrent motoneuron discharge, or F-waves when measured with surface
EMG, after supramaximal stimulation of a motor nerve
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(Fisher, 1992; McNeil et al., 2013; Mesrati &
Vecchierini, 2004). F-waves reflect the antidromic activation and subsequent backfiring of motoneurons. Hence,
the generation of F-waves does not require synaptic
input. We found that 5-HT2 antagonism reduced the
amplitude and persistence of recurrent motoneuron discharge, which demonstrates reductions in motoneuron
excitability with reduced 5-HT2 receptor activity.
Considering that recurrent discharge was generated
in motoneurons that are otherwise below their threshold
for discharge (prior to stimulation), drug reductions in
motoneuron excitability can be attributed to effects on
resting membrane properties and not PICs. In guinea pig
motoneurons, 5-HT2 receptor activation increases excitability below recruitment threshold by inhibiting leak
potassium channels and facilitating a hyperpolarization
activated inward current (Hsiao et al., 1997). In our
study, 5-HT2 antagonism could have combatted these
facilitatory effects to reduce motoneuron excitability and
reduce F-waves. However, this does not explain why
muscle responses to antidromic but not synaptic activation of motoneurons were affected by drug, as overall
changes in intrinsic properties of motoneurons affect
both measures. One possibility is that drug administration affected the motoneuron soma to reduce the time
between antidromic and orthodromic spikes at the axon
initial segment. Although speculative, 5-HT2 antagonism
with cyproheptadine could have reduced the amplitude
of the persistent sodium current, which is faster to activate than persistent calcium currents (Heckman,
Johnson, et al., 2008), to reduce the duration of somatic
depolarization. In turn, a shorter duration somatic depolarization would increase the likelihood of an orthodromic spike reaching a refractory axon initial segment.
Although there is limited evidence for this idea, 5-HT2
receptors facilitate sodium PICs in rat motoneurons
(Harvey et al., 2006a, 2006b).
Another possibility is that cyproheptadine differently
affected different motoneuron types. F-waves represent
the recurrent discharge of higher threshold motoneurons,
as the simultaneous stimulation of Ia afferents initiates
orthodromic spikes in lower threshold motoneurons that
collide with the antidromic spikes that generate recurrent
discharge (Espiritu et al., 2003). By contrast, stimulation
of corticospinal axons recruits motoneurons in an orderly
fashion from lower to higher threshold (Bawa &
Lemon, 1993). In this regard, as we set the intensity of
cervicomedullary stimulation to elicit small CMEPs
(10% of Mmax), CMEPs in this study reflect the excitability of lower threshold motoneurons. As F-waves but not
CMEPs were reduced with drug, this indicates that 5-HT2
antagonism may have affected higher threshold motoneurons more than lower threshold.
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4.3 | 5-HT2 antagonism reduces motor
output
Although there is a low level of tonic 5-HT release to
motoneurons in the waking state, stimulation assessed
motoneuron excitability under conditions with no
ionotropic drive to activate motoneurons. However, voluntary motor activity causes greater 5-HT release to
motoneurons (Jacobs et al., 2002; Veasey et al., 1995),
and neuromodulatory effects at motoneurons are strongest with high-intensity motor activities involving strong
serotonergic drive and sustained ionotropic input to activate PICs (Heckman et al., 2003, 2009). Our maximal
contraction findings are consistent with this, as 5-HT2
antagonism reduced the force generated during maximal
contractions. This is not an accidental finding, as
enhanced 5-HT availability increases maximal strength
and/or voluntary activation (Kavanagh et al., 2019;
Thorstensen et al., 2020), and maximal contractions were
also negatively affected with 5-HT2 antagonism in a previous study (Thorstensen et al., 2021). Considering that
maximal contractions are generated via sustained input
to motoneurons, we suggest that 5-HT2 antagonism
reduced the amplitude of PICs to negatively affect the
ability of participants to voluntarily activate motoneurons
leading to reductions in muscle force.

4.4 | Considerations
Both stimulation techniques assessed a small proportion
of the motoneuron pool and thus might not reflect overall
changes in excitability, and cyproheptadine may have
affected biceps and ADM pools differently. Also, increases
or decreases in F-wave amplitude or persistence do not
always represent corresponding increases or decreases in
motoneuron excitability (Balbi, 2016; Balbi et al., 2014;
Lin & Floeter, 2004). As afferent fibres are also activated
with supramaximal stimulation of peripheral nerves and
5-HT modulates afferent input to motoneurons (D’Amico,
Li, et al., 2013; Murray, Stephens, Rank, et al., 2011), 5-HT
effects on F-waves could potentially be a consequence of
pre-synaptic mechanisms. However, the serotonergic control of afferent input to human motoneurons is via
5-HT1B/D receptors (D’Amico, Li, et al., 2013), and cyproheptadine has weak effects at these receptors.
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F-waves with 5-HT2 antagonism. Considering that assessments of motoneuron excitability were obtained when
muscles were inactive and thus, motoneurons were otherwise below their threshold for discharge, the reduced
recurrent discharge of motoneurons with 5-HT2 antagonism suggests that 5-HT modulates the resting membrane
properties of the axon initial segment or soma to promote
motoneuronal excitability. In addition, as 5-HT2 antagonism had no effect on motoneuron excitability to brief
synaptic input, but affected maximal contractions requiring sustained synaptic input, it is likely that the 5-HTmediated amplification of synaptic input at motoneurons
is strong only when dendritic PICs are activated.
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This study provides novel in vivo evidence that 5-HT2
receptors play a role in controlling the excitability of
human motoneurons, as evidenced by reductions in
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